🚀 Are there any significant product launches or developments from ADAP in the near future?

Adaptimmune Therapeutics (ADAP) has several significant developments and product launches planned or underway in the near future: 1. **Launch of Leticel**: The company is preparing for the launch of Leticel in 2026, which is expected to significantly expand the patient base. 2. **Ongoing Clinical Trials**: The company continues to advance its clinical trials, including the use of T-cell therapies for various indications. These developments could have a significant impact on the company's future growth and market position. Investors may find these developments promising, especially the upcoming launch of Leticel, which could drive future revenue and market expansion.